Effects of Digital Detox on Mental Health in Young Adults
Effects of Digital Detox on Mental Health in Young Adults: A Randomized Controlled Trial
The goal of this clinical trial is to learn whether a short, self-guided program for cutting down smartphone screen time can reduce symptoms of depression in young adults. It includes students in Oslo, Norway, who have applied for help at the student mental health service (SiO Mental Health).
The main questions it aims to answer are:
- Does a 2-week screen time reduction program reduce symptoms of depression?
- Does it reduce symptoms of anxiety?
- Can a simple, widely available phone app reduce screen time, and does the reduction last?
Researchers will compare students who start the program right away with students who continue their usual care for 2 weeks and receive the same program afterwards. Participants are placed in one of the two groups by chance, like flipping a coin.
Participants will:
- Answer questionnaires about depression and anxiety symptoms at the start and again after 2 weeks
- Upload screenshots of the Screen Time summary on their iPhone at the start, after 2 weeks, and after 12 weeks
- Install an app that blocks the apps they find most distracting and keep it active for 2 weeks, if they are placed in the program group
- Take part entirely online, with no clinic visits and no contact with the study team
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Thomas Mildestvedt, Professor
- Telefonnummer: +47 55586163
- E-mail: thomas.mildestvedt@uib.no
Studiesteder
-
-
-
Oslo, Norge
- Studentsamskipnaden i Oslo
-
Kontakt:
- Thomas Mildestvedt, Professor
- Telefonnummer: +47 55586163
- E-mail: thomas.mildestvedt@uib.no
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Has applied for care at SiO Mental Health, the student mental health service in Oslo, and has received the service's response to the application
- Owns an iPhone (the screen time restriction tool requires iOS)
- Able to understand written Norwegian
- Provides informed consent
Exclusion Criteria:
- None
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Ingen indgriben: Pas på som sædvanlig
|
|
|
Eksperimentel: Screen time reduction
|
Two-week self-guided use of an iOS screen time restriction app. Participants block their most distracting apps, with notifications disabled. Unlocking requires a 30-second delay, allows 10 minutes of access, then a 5-minute cooldown. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Symptoms of depression (PHQ-9)
Tidsramme: From enrollment to the end of intervention at 2 weeks
|
Patient Health Questionnaire-9, range 0 to 27, higher scores indicate more depressive symptoms. |
From enrollment to the end of intervention at 2 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Total smartphone screen time
Tidsramme: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Smartphone screen time by app category
Tidsramme: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Number of daily smartphone pickups
Tidsramme: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Symptoms of anxiety (GAD-7)
Tidsramme: From enrollment to the end of intervention at 2 weeks
|
Generalized Anxiety Disorder-7, range 0 to 21, higher scores indicate more anxiety symptoms. |
From enrollment to the end of intervention at 2 weeks
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-reported changes in daily functioning and well-being
Tidsramme: 2 weeks
|
Twelve single-item questions on perceived change over the past 2 weeks, each answered on a 5-point scale from 1 (much less than usual) to 5 (much more than usual). The domains are sleep, time spent with others, physical activity, time on other screens (computer, tablet), loneliness, satisfaction with oneself, rumination on negative thoughts, feeling of missing out, stress, ability to concentrate, satisfaction with own study effort, and getting done what one plans. Higher scores indicate more of the attribute than usual. Whether a higher score represents a better outcome depends on the domain. |
2 weeks
|
|
Adherence to the screen time restriction tool
Tidsramme: 2 weeks
|
Self-reported proportion of the 2-week period with the blocking rule kept active, answered on a 5-level ordinal scale: all of the time, most of the time, part of the time, little of the time, none. Higher levels indicate greater adherence. Reported by the intervention group. |
2 weeks
|
|
Perceived usefulness and burden of the tool
Tidsramme: 2 weeks and 12 weeks
|
Perceived usefulness of the tool for reducing screen time and perceived burden in everyday life, each answered on a 5-point scale from 1 (not at all) to 5 (to a very great extent), and a single question on intention to continue use (yes, no, do not know). Higher usefulness indicates a better outcome and higher burden a worse outcome. Reported by the intervention group at 2 weeks and by both groups at 12 weeks. |
2 weeks and 12 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Thomas Mildestvedt, Professor, University of Bergen
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 1000700
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Anonymized individual participant data underlying the published results.
IPD-delingstidsramme
After publication of the primary results.
IPD-delingsadgangskriterier
Upon request to the principal investigator, under a data sharing agreement.
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- ICF
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .